http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-012845-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89df1827de2715e4a4d4358ac37677bd
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-02
filingDate 2005-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86b10103cac9f048622f2d93df10e56c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43fbbf8fca31cb9f4106f3547cc84e18
publicationDate 2009-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-012845-B1
titleOfInvention PHARMACEUTICAL COMPOSITION CONTAINING ZOFENOPRYL AND HCTZ FOR TREATMENT OF HYPERTENSION
abstract The invention relates to oral dosage forms containing zofenopril calcium salt, in particular to solid oral dosage forms containing a combination of polymorphic modification A of zofenopril, essentially without admixture of polymorphic modification B, and hydrochlorothiazide (HCTZ), and to methods for their preparation.
priorityDate 2005-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4452790-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6515012-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2229298-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500097
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID59272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451285230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451285229
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454521068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71753025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42624899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3639

Total number of triples: 35.